Ahmed OsamaOsamaGaberMD

Pancreas, Transplantation

Professor of Surgery

Telehealth Available

Overview of Dr. Gaber

Dr. Ahmed Osama Gaber is a general surgeon in Houston, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital and Houston Methodist Sugar Land Hospital. He received his medical degree from Ain Shams University Faculty of Medicine and has been in practice 40 years. He is one of 155 doctors at Houston Methodist Hospital and one of 40 doctors at Houston Methodist Sugar Land Hospital who specialize in General Surgery. He has more than 100 publications and over 500 citings.

Office
6550 Fannin St
Ste 1661
Houston, TX 77030
Book by Phone+1(346) 547-0890

Fax+1 713-790-6839

Education & Training

Boston University Medical CenterResidency, Surgery, 1981 - 1985
Ain Shams University Faculty of MedicineClass of 1976

Certifications & Licensure

TX State Medical License 2006 - 2026
TN State Medical License 1987 - 2007
IL State Medical License 1985 - 1987
ME State Medical License Active through 1984
American Board of Surgery Surgery

Clinical Trials

Study of ISA247 (Voclosporin) in De Novo Renal Transplantation Start of enrollment: 2006 Jan 01
Completed
Phase 2
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation Start of enrollment: 2010 Nov 01
Terminated
Phase 2
A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients Start of enrollment: 2014 Jul 01
Terminated
A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant Start of enrollment: 2016 May 20
Terminated
Phase 3
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation Start of enrollment: 2016 Dec 01
Recruiting
Phase 2
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx Start of enrollment: 2021 Oct 14
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys Start of enrollment: 2023 Apr 21
RECRUITING
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Impact of Therapeutic Plasma Exchange and Rituximab for Prevention of Idiopathic Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation.
Allison N Yun, Alex W Rogers, Jill C Krisl, Anna Kagan, Horacio E Adrogue
Transplantation Direct. 2025-03-01
Determining Predictors of Actual Living Kidney Donation Based on Potential Donor Characteristics.
Andrea M Meinders, Edward A Graviss, Duc T Nguyen, Jonathan Daw, Krista L Lentine
Clinical Transplantation. 2024-09-01
2 citations
Clinical Outcomes of Heart Transplant Recipients Admitted with COVID-19 Infection in 2020: A Nationwide Analysis.
Omar Tamimi, Faisal Tamimi, Tariq Nisar, Ahmed Osama Gaber, Jiejian Lin
Current Problems in Cardiology. 2023-12-01

Grant Support

Effect Of Dietary Supplements In African American Kidney Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2007
Optimization On Islet Isolation: Type 1 Diabetes: TransplantationNational Center For Research Resources2004–2005
Impact Of Standardization And Procedure Optimization On*National Center For Research Resources2003–2005
Enhancement Of Human Islet Engraftment By Gene TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
Standardization And Procedure On Islet IsolationNational Center For Research Resources2001